Entrada Therapeutics(TRDA)
BOSTON, MA
BiotechnologyFocus: Biologics delivered to cytosol
Entrada Therapeutics is a life sciences company focused on Biologics delivered to cytosol.
Rare DiseasesNeurologyOphthalmologyGastroenterology
Funding Stage
PUBLIC
Open Jobs
9
Pipeline & Clinical Trials
Non-interventional
Mitochondrial Neurogastrointestinal EncephalomyopathyClinical Trials (1)
NCT04245917Natural History Study of MNGIE
N/AENTR-601-44
Duchenne Muscular Dystrophy (DMD)Clinical Trials (1)
NCT07037862A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
Phase 1/2ENTR-601-45
Duchenne Muscular Dystrophy (DMD)Clinical Trials (1)
NCT07038824A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
Phase 1/2Open Jobs (9)
Executive Assistant
Boston, MA
Corporate G&A4d ago
$100K - $130K/yr
Executive Director, Investor Relations
Boston, MA
Finance5d ago
$292K - $395K/yr
Associate Director, Drug Substance Development & Manufacturing
Boston, MA
Supply Chain2w ago
$172K - $202K/yr
Associate Director, Clinical Biomarkers
Boston, MA
Clinical Development2w ago
Pharmacometrics Consultant
Boston, MA
Clinical Development2w ago
Associate Director, Pharmacometrics
Boston, MA
Clinical Development2w ago
$180K - $236K/yr
Manager, Clinical Data Management
Boston, MA
TEMPLATE PLACEHOLDER2w ago
$138K - $166K/yr
Associate Director, Clinical Outsourcing
Boston, MA
Clinical Operations2w ago
$173K - $203K/yr
Clinical Trial Manager
Boston, MA
Clinical Operations2w ago
$136K - $163K/yr
Interview Prep Quick Facts
Portfolio: 3 clinical trials
SEC Filings: 2 available
Open Roles: 9 active jobs
Financials (FY2025)
Revenue
$211M63%
R&D Spend
$125M(59%)25%
Net Income
$66MCash
$101MHiring Trend
Stable
9
Open Roles
+2
Added
-0
Filled/Removed
Based on last 4 crawl cycles